Page last updated: 2024-08-16

sk&f 86002 and mocetinostat

sk&f 86002 has been researched along with mocetinostat in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Clayton, MK; Cooley, AJ; Darien, BJ; Hart, AP; Kruse-Elliott, KT; MacWilliams, PS; Schram, BR; Triplett, EA1

Other Studies

2 other study(ies) available for sk&f 86002 and mocetinostat

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
SK&F 86002, a dual cytokine and eicosanoid inhibitor, attenuates endotoxin-induced cardiopulmonary dysfunction in the pig.
    Shock (Augusta, Ga.), 1996, Volume: 6, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Eicosanoids; Endotoxemia; Heart; Imidazoles; Lipopolysaccharides; Lung; Peroxidase; Stroke Volume; Swine; Thiazoles; Thromboxanes; Tumor Necrosis Factor-alpha; Vascular Resistance

1996